Crain’s Chicago Business: ‘The Koosh Ball’ that can cure
November 08, 2018
EVANSTON, Ill.—International Institute for Nanotechnology (IIN) Director Chad Mirkin and David Giljohann, Northwestern professor and CEO of IIN-startup Exicure, Inc., discuss how spherical nucleic acids, or SNAs, developed at Northwestern, are transforming aspects of drug delivery and pharmaceutical development. Read the full article in Crain’s Chicago Business.
The International Institute for Nanotechnology at Northwestern University is an umbrella organization that represents and unites more than $1 billion in nanotechnology research, education and supporting infrastructure.